About Nipro Corporation
Nipro Corporation is a publicly listed company based in Osaka (Japan) founded in 1954. The company has 39,170 employees. Nipro Corporation has completed 2 acquisitions, including Home Diagnostics and Infraredx. Its website nipro.co.jp draws about 161 thousand monthly visits. Nipro Corporation offers products and services including Medical Devices and Regenerative Medicine. Its focus areas include Traditional Medical Devices, Medical Device Outsourcing and Contract Manufacturing.
Company details
Manufacturer of medical devices, pharmaceuticals, and regenerative medicine products. The company develops and manufactures a diverse portfolio of products, including dialysis equipment, various medical instruments, and a range of pharmaceuticals. A significant portion of their business focuses on regenerative medicine, offering products contributing to advancements in this field. Their operations encompass research and development, manufacturing, and distribution.
- Headquarters Osaka, Japan
- Employees 39,170
- Stage Public
- SectorsHealthcare
- Website category Health
- Phone•••• ••••
- Website nipro.co.jp
- Social Instagram
- Legal Name Nipro Corporation
- Annual Revenue$4.14 B (USD)2.47as on Mar 31, 2026
- Net Profit$84.64 M (USD)164.06as on Mar 31, 2026
- EBITDA$635.5 M (USD)9.88as on Mar 31, 2026
- Employee Count39,170
- Investments & AcquisitionsHome Diagnostics
& 1 more
Products & Services of Nipro Corporation
Nipro Corporation offers a comprehensive portfolio of products and services, including Medical Devices and Regenerative Medicine.
Medical devices including dialyzers and syringes are manufactured to respond to medical site needs.
Regenerative medical products are developed and supplied to address treatments for conditions like spinal injuries.
People of Nipro Corporation
34 people are tracked at Nipro Corporation (9 in leadership, 25 in team); the tracked headcount is 39,170.
| Name | Role | Group |
|---|---|---|
Yoshihiko Sano | President | Leadership |
James Daley | Director Of Operations And Engineering | Leadership |
Dina Silva | Director, Human Resources - North America | Leadership |
Efraim Figueroa | Director Of Clinical Education | Leadership |
John O'Connor | Director, Vascular Division | Leadership |
Jessica Oswald-McLeod | Director Quality And Regulatory, ASQ CQA | Leadership |
Timothy Hale | Head Of Marketing, North America | Leadership |
Lianne Fernandes | Director Of Operations | Leadership |
Mike Wessler | Director Of Supply Chain | Leadership |
Sheri Fonte | Supply Chain Specialist | Team |
Natalie Geremia | Clinical Specialist | Team |
Michael Kooienga | Clinical Specialist | Team |
Payal Waghmbare | Junior Customer Engineer | Team |
Bushra H. | Product Engineer | Team |
Mathew Thomas | Sr. Manager, Technical Development | Team |
Barry Stazzone | Procuct Development And Test Engineer | Team |
Katie Sitton | National Clinical Specialist - Vascular | Team |
Valerie Colon | Import Specialist,coordinator In House | Team |
Lautaro González Arenas - General Manager | Renal Division Manager & Boutique Project | Team |
Euridice Boffard | Supply Chain Specialist | Team |
14 more people are available in the full profile.
Complete people profiles for Nipro Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Nipro Corporation
Nipro Corporation is a publicly listed company on the TSE with ticker symbol 8086 in Japan, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Dec 1996
- Listed onTSE: 80860
- Listed entityNIPRO Corporation
- Exchange sectorDistribution services
- ISINJP3673600007
- Share price1,354.00 JPY (+0.26% on the day) · 2026-10-14
- Market capitalisation220,262,416,237.00 JPY
- Price to earnings18.2
- EPS (diluted, trailing year)74.54 JPY
- Dividend yield2.35%
- Volume (last session)962,700
Financials of Nipro Corporation
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 660.54B JPY | 13.50B JPY | 101.36B JPY |
| 2024 | 644.59B JPY | 5.11B JPY | 92.25B JPY |
| 2023 | 586.78B JPY | 11.11B JPY | 81.21B JPY |
| 2022 | 545.20B JPY | 4.58B JPY | 66.47B JPY |
| 2021 | 494.79B JPY | 13.46B JPY | 70.05B JPY |
Detailed financial statements for Nipro Corporation
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nipro Corporation
Nipro Corporation has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Home Diagnostics and Infraredx.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Coronary imaging and plaque detection system | infraredx.com | Burlington, United States | 1998 | Sep 2015 | •••• | |
Home blood glucose monitoring systems are developed and marketed. | homediagnostics.com | Fort Lauderdale, United States | 1985 | Feb 2010 | $215M |
Complete acquisition details for Nipro Corporation
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nipro Corporation
4 dated milestones of Nipro Corporation across 61 years, from founding to its latest funding, stage changes and deals.
- Founded Nipro Corporation is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Home Diagnostics.
- Acquisition Acquires Infraredx.
Web traffic of Nipro Corporation
The website of Nipro Corporation (nipro.co.jp) receives about 160.7K visits a month and ranks #244,538 among all websites worldwide, #8,207 in Health.
- Monthly visits160.7K
▼ 2.5% vs previous month
- Unique visitors101.5K
per month
- Global rank#244,538
among all websites
- Category rank#8,207
Health · Health
- Bounce rate53%
- Pages per visit2.5
- Average visit2 min 05 sec
- DevicesDesktop 63% · Mobile 37%
Websites whose visitors overlap most with Nipro Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hitachi-medical.co.jp | hitachi-medical.co.jp | 100% | – | ||
toshiba-medical.co.jp | toshiba-medical.co.jp | 97% | – | ||
muranaka.co.jp | muranaka.co.jp | 93% | #694,728 | – | |
fukuda.co.jp | fukuda.co.jp | 93% | #311,831 | – | |
top-tokyo.co.jp | top-tokyo.co.jp | 93% | #464,216 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Nipro Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nipro Corporation
Complete news archive for Nipro Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nipro Corporation
Nipro Corporation was founded in 1954.
Nipro Corporation is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Nipro Corporation has 39,170 employees.
Annual revenue of Nipro Corporation is $4.14B as on Mar 31, 2026.
Manufacturer of medical devices, pharmaceuticals, and regenerative medicine products. The company develops and manufactures a diverse portfolio of products, including dialysis equipment, various medical instruments, and a range of pharmaceuticals. A significant portion of their business focuses on regenerative medicine, offering products contributing to advancements in this field. Their operations encompass research and development, manufacturing, and distribution.
Nipro Corporation offers Medical Devices and Regenerative Medicine.
Yes, Nipro Corporation is publicly traded on TSE under the ticker symbol 8086.
Nipro Corporation has made 2 acquisitions, including Home Diagnostics, and Infraredx.
Nipro Corporation operates through Nipro Corporation.
The website of Nipro Corporation receives about 161 thousand visits a month and ranks #244,538 among all websites worldwide.